NGM BIOPHARMACEUTICALS INC Accrued Liabilities, Current
NGM BIOPHARMACEUTICALS INC had Accrued Liabilities, Current of $17.10 million as of 2023-12-31, per its 10-K filed 2024-03-11.
Discontinued › Balance Sheet › Liabilities › Liabilities, Current › Accounts Payable and Accrued Liabilities, Current › Accrued Liabilities, Current
us-gaap:AccruedLiabilitiesCurrent · last filed 2024-03-11
- 2023-12-31: Accrued Liabilities, Current $17.10M.
- 2023-09-30: Accrued Liabilities, Current $16.17M.
- 2023-06-30: Accrued Liabilities, Current $19.13M.
- 2023-03-31: Accrued Liabilities, Current $20.16M.
| Period end | Accrued Liabilities, Current |
|---|---|
| 2023-12-31 | $17.10M 10-K · filed 2024-03-11 |
| 2023-09-30 | $16.17M 10-Q · filed 2023-11-02 |
| 2023-06-30 | $19.13M 10-Q · filed 2023-08-03 |
| 2023-03-31 | $20.16M 10-Q · filed 2023-05-04 |
| 2022-12-31 | $33.64M 10-K · filed 2024-03-11 |
| 2022-09-30 | $32.76M 10-Q · filed 2022-11-03 |
| 2022-06-30 | $23.94M 10-Q · filed 2022-08-04 |
| 2022-03-31 | $29.48M 10-Q · filed 2022-05-05 |
| 2021-12-31 | $33.26M 10-K · filed 2023-02-28 |
| 2021-09-30 | $34.72M 10-Q · filed 2021-11-04 |
| 2021-06-30 | $31.89M 10-Q · filed 2021-08-05 |
| 2021-03-31 | $29.76M 10-Q · filed 2021-05-06 |
| 2020-12-31 | $29.95M 10-K · filed 2022-03-01 |
| 2020-09-30 | $28.58M 10-Q · filed 2020-11-12 |
| 2020-06-30 | $26.79M 10-Q · filed 2020-08-12 |
| 2020-03-31 | $21.95M 10-Q · filed 2020-05-13 |
| 2019-12-31 | $22.99M 10-K · filed 2021-03-15 |
| 2019-09-30 | $18.61M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $15.29M 10-Q · filed 2019-08-12 |
| 2019-03-31 | $13.92M 10-Q · filed 2019-05-16 |
| 2018-12-31 | $14.00M 10-K · filed 2020-03-17 |